vimarsana.com

Latest Breaking News On - Cingulate inc stock exchange - Page 1 : vimarsana.com

Cingulate to Present at 13th Annual LD Micro Invitational

KANSAS CITY, Kan., May 25, 2023 Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a. | May 25, 2023

Kansas cityUnited statesThomas daltonShanej schafferLos angelesMatt krepsCingulate incDarrow associates investor relationsPrecision timed releaseLuxe sunset boulevard hotelPublic relationsCingulate inc stock exchangePress releaseDvance cing us17248w1053

Cingulate : Market Offering Agreement - Form 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT . | May 5, 2023

United statesShanej schafferHc wainwright coSecurities exchangeOpinion of lowenstein sandlerCingulate incNasdaq stock marketConsent of lowenstein sandlerSecurities exchange actZip codeGeneral instructionSecurities actExchange actNasdaq capital marketCommon stockSales agreement

Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO

Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced Clinical Timelines for Phase 3 Trial ProgramKANSAS CITY, Kan., May 03, 2023 Cingulate Inc. ,. | May 3, 2023

United statesKansas citySan diegoMelyssa weibleMatt krepsThomas daltonShanej schafferDavid enloeDarrow associatesPlatform technologyElixir health public relationsMaster services agreementTrial programScience to societyExchange commissionCingulate inc

Cingulate : Announces Successful Transfer of CTx-1301 (dexmethylphenidate) - Form 8-K

Cingulate Announces Successful Transfer of CTx-1301 Proprietary PTR™ Manufacturing Processes to Societal CDMO Scalable Supply of CTx-1301 Ready to be. | May 3, 2023

United statesKansas citySan diegoDavid enloeShanej schafferMatt krepsMelyssa weibleThomas daltonExchange commissionPlatform technologySecurities exchangeElixir health public relationsTrial programSocietal cdmo incScience to societyMaster services agreement

Cingulate to Participate in Benzinga All Live Access Event

KANSAS CITY, Kan., April 14, 2023 Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a. | April 14, 2023

United statesKansas cityThomas daltonMelyssa weibleMatt krepsBenzinga youtubeShanej schafferCingulate incElixir health public relationsDarrow associatesPrecision timed releaseBenzinga all accessTuesday aprilHyperactivity disorderPublic relationsCingulate inc stock exchange

vimarsana © 2020. All Rights Reserved.